SAN DIEGO, Jan. 09, 2022 Exagen Inc. , a leading provider of autoimmune testing solutions, and Queen Mary University of London, announced today the execution of a research. | January 9, 2022
Exagen Inc and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.